These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3131096)
1. Fluvoxamine (Faverin): another antidepressive drug. Drug Ther Bull; 1988 Feb; 26(3):11-2. PubMed ID: 3131096 [No Abstract] [Full Text] [Related]
2. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder. Mullin JM; Pandita-Gunawardena VR; Whitehead AM Br J Clin Pract; 1988 Feb; 42(2):51-5. PubMed ID: 3140864 [No Abstract] [Full Text] [Related]
3. A Belgian multicentre study of fluvoxamine in depressive outpatients. Brasseur R; Van Moffaert M; Mesotten F; Ansseau M; Uytdenhoef P; Bartholome F Acta Psychiatr Belg; 1985; 85(5):636-43. PubMed ID: 3937441 [TBL] [Abstract][Full Text] [Related]
4. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression. Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916 [No Abstract] [Full Text] [Related]
5. [Fantasy and reality: fluvoxamine. International symposium, Füssen, 4 May 1991]. Nervenarzt; 1991 Jun; 62(6 Suppl):1-12. PubMed ID: 1906141 [No Abstract] [Full Text] [Related]
6. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression. Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993 [TBL] [Abstract][Full Text] [Related]
7. Long-term study of fluvoxamine: a new rapid-acting antidepressant. Feldmann HS; Denber HC Int Pharmacopsychiatry; 1982; 17(2):114-22. PubMed ID: 6809683 [TBL] [Abstract][Full Text] [Related]
8. Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine. Coleman BS; Block BA Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):475-8. PubMed ID: 6819596 [TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression. Roth D; Mattes J; Sheehan KH; Sheehan DV Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):929-39. PubMed ID: 2126144 [TBL] [Abstract][Full Text] [Related]
10. [The role of drugs in the treatment of obsessive-compulsive disorders]. den Boer JA; Westenberg HG Ned Tijdschr Geneeskd; 1990 Mar; 134(10):503-4. PubMed ID: 2107405 [No Abstract] [Full Text] [Related]
11. Fluvoxamine--a baseline study of clinical response, long term tolerance and safety in a general practice population. Martin AJ; Wakelin J Br J Clin Pract; 1986 Mar; 40(3):95-9. PubMed ID: 3085700 [No Abstract] [Full Text] [Related]
17. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Benfield P; Ward A Drugs; 1986 Oct; 32(4):313-34. PubMed ID: 3096686 [TBL] [Abstract][Full Text] [Related]
18. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine. Freeman HL; Wakelin JS; Calanca A; Hole G Adv Biochem Psychopharmacol; 1982; 32():69-75. PubMed ID: 7046368 [No Abstract] [Full Text] [Related]
19. New antidepressants. Kupecz D Nurse Pract; 1995 Sep; 20(9):64-7. PubMed ID: 7501318 [No Abstract] [Full Text] [Related]
20. [New horizons in drug therapy of depression]. Sirota P; Kaspi N Harefuah; 1992 Jun; 122(11):712-6. PubMed ID: 1526564 [No Abstract] [Full Text] [Related] [Next] [New Search]